Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen alpha-1(VII) chain, encoded by the COL7A1 gene, is a crucial component of anchoring fibrils that connect the epidermal basement membrane to the underlying dermis in stratified squamous epithelia. It is essential for maintaining skin and mucosal membrane integrity. Mutations in COL7A1 lead to various forms of dystrophic epidermolysis bullosa, while autoimmune responses against type VII collagen cause epidermolysis bullosa acquisita. As such, it is a therapeutic target, but there are no drugs that directly target it.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen alpha-1(VII) chain (COL7A1).